Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania
1 other identifier
interventional
167
1 country
1
Brief Summary
This study will test a stigma reduction intervention with women living with HIV in Tanzania.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2021
CompletedFirst Posted
Study publicly available on registry
September 2, 2021
CompletedStudy Start
First participant enrolled
October 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2024
CompletedResults Posted
Study results publicly available
May 29, 2025
CompletedMay 29, 2025
May 1, 2025
1.6 years
August 31, 2021
May 7, 2025
May 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Number of Participants Recruited as Measured by Enrollment Logs
up to 6 months
Number of Study Participants Retained in Study as Measured by Enrollment Logs
30, 90, and 180 days after intervention
Percent of Questions Left Blank on Study Instruments
baseline and 30, 90, and 180 days after intervention
Time it Takes in Minutes for Participants to Complete the Questionnaires
baseline and 30, 90, and 180 days after intervention
Number of Women Who Completed All 5 Sessions
up to 5 weeks
Secondary Outcomes (5)
Change in Internalized Stigma, as Measured by the Swahili Version of the Multidimensional Measure of Internalized Stigma Scale
baseline and 30, 90, and 180 days after intervention
Change in Coping Self-efficacy, as Measured by the Swahili Version of the Coping Self-Efficacy Scale
baseline and 30, 90, and 180 days after intervention
Change in Self-esteem, as Measured by the Swahili Version of the Rosenberg Self-Esteem Scale
baseline and 30, 90, and 180 days after intervention
Hope, as Measured by the Swahili Version of the State of Hope Scale
Baseline
Change in Depressive Symptoms, as Measured by the Swahili Version of the Patient Health Questionnaire 9
baseline and 30, 90, and 180 days after intervention
Study Arms (2)
Treatment as Usual Group
NO INTERVENTIONThis group will receive treatment as usual which means that no formal stigma reduction intervention will be provided. At the end of the follow-up period, this group will be invited to view the Labda Siku Moja stigma reduction intervention without follow-up.
Stigma Intervention Group
EXPERIMENTALThis group will participate in a 5 week intervention. Each week, intervention group participants will watch one ethnodrama segment of the Labda Siku Moja stigma reduction intervention followed by a guided debrief using motivational interviewing.
Interventions
The Labda Siku Moja stigma reduction intervention is a tailored stigma reduction intervention for women living with HIV in Tanzania. It is comprised of five ethnodramas (video stories) culturally and linguistically relevant to the Tanzanian women living with HIV.
Eligibility Criteria
You may qualify if:
- (1) women who are living with HIV;
- (2) age 18 (age of adulthood as defined by the Tanzanian government);
- (3) able and willing to voluntarily consent to participate in the study;
- (4) able to travel to a data collection in their local community (as described above);
- (5) demonstrate mental competence at time of informed consent;
- (6) verbally indicate that they plan to reside in their current community for at least 6 months after enrollment (necessary to prevent attrition);
- (7) score at the median or higher level on the Swahili Version of the Multidimensional Measure of Internalized HIV Stigma Scale.
You may not qualify if:
- (1) any acute psychological or physiological distress; if there is evidence of acute psychologic and/or physiologic, they will be excluded from this study and referred to an appropriate site for evaluation and treatment.
- (2) Transgender women living with HIV will not be eligible to participate in this study to reduce the potential for confounding sources of stigma recognizing that a transgender identity is highly stigmatized and culturally sensitive in Tanzania. Further, it would be exceedingly difficult to recruit a sufficient sample of transgender women living with HIV to conduct an appropriate analysis.
- (3) Participants may be enrolled in other HIV-related studies except cognitive-behavioral intervention studies addressing stigma, self-efficacy, self-esteem, and/or disclosure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Muhimbili University of Health and Allied Sciencescollaborator
- RTI Internationalcollaborator
Study Sites (1)
Muhimbili University of Health and Allied Sciences
Dar es Salaam, Tanzania
Related Publications (1)
Nyblade L, Kilonzo MN, Kisamo DH, Mtei RJ, Pan W, Relf MV. Efficacy Testing of a Culturally Relevant Stigma Reduction Intervention for Women Living With HIV in Tanzania: Protocol for a Randomized Controlled Trial. J Assoc Nurses AIDS Care. 2025 Mar 26;36(5):470-481. doi: 10.1097/JNC.0000000000000538.
PMID: 40138392DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael Relf, Ph.D.
- Organization
- Duke University School of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Michael V. Relf, PhD
Duke University School of Nursing
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2021
First Posted
September 2, 2021
Study Start
October 24, 2022
Primary Completion
May 16, 2024
Study Completion
May 28, 2024
Last Updated
May 29, 2025
Results First Posted
May 29, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share